Trials / Conditions / Child Development Disorders, Pervasive

Child Development Disorders, Pervasive

19 registered clinical trials studyying Child Development Disorders, Pervasive — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Effect of Problem-Solving Training NCT05688319	Ataturk University	N/A
Completed	Arabic NODA Validation Study for Autism Diagnosis in Saudi Arabia NCT07089108	Prince Sultan Military Medical City	—
Completed	A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of RO69539 NCT04475848	Hoffmann-La Roche	Phase 1
Recruiting	SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism NCT03222375	American Federation of Medical Synergetics	—
Completed	Using Mobile Technology to Reduce Stereotypy NCT02124720	Université de Montréal	N/A
Completed	Using the Prevent-Teach-Reinforce Model to Reduce Problem Behaviors in Children With Autism Spectrum Disorders NCT02153203	Université de Montréal	N/A
Completed	Shared Decision Making to Improve Care and Outcomes for Children With Autism NCT01921244	Children's Hospital Medical Center, Cincinnati	N/A
Completed	Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents NCT01731119	University of North Carolina, Chapel Hill	Phase 2
Terminated	Assessing Suicide Risk in Adolescents With Developmental Delays NCT01517126	National Institute of Mental Health (NIMH)	—
Completed	Trial of Therapeutic Horseback Riding in Children and Adolescents With Autism Spectrum Disorder NCT02301195	University of Colorado, Denver	N/A
Completed	Randomized Trial of Parent Training for Young Children With Autism NCT01233414	Yale University	N/A
Completed	Social Skills and Anxiety Reduction Treatment for Children and Adolescents With Autism Spectrum Disorders NCT00926471	Virginia Polytechnic Institute and State University	Phase 1
Terminated	A Prospective Study Comparing the Mifne Approach of Treating Childhood Autism With Routine Standard Treatment NCT00445471	Rabin Medical Center	N/A
Completed	A Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders NCT00453180	Indiana University School of Medicine	Phase 2
Withdrawn	Mercury Chelation to Treat Autism NCT00376194	National Institute of Mental Health (NIMH)	Phase 2
Unknown	Safety and Efficacy Study in the Treatment of Intestinal Problems Associated With Autism NCT00110708	PediaMed Pharmaceuticals	Phase 2
Completed	RUPP PI PDD: Drug and Behavioral Therapy for Children With Pervasive Developmental Disorders NCT00080145	Yale University	N/A
Completed	Pharmacogenetics of Risperidone in Children With Pervasive Developmental Disorder (PDD) NCT00166595	Children's Hospital Medical Center, Cincinnati	Phase 1 / Phase 2
Completed	Risperidone Pharmacokinetics in Children With Pervasive Developmental Disorder (PDD) NCT00147394	Children's Hospital Medical Center, Cincinnati	Phase 1